Accessibility Tools
  • Enhancing the Adjuvant Treatment of Hormone Receptor Positive Breast Cancer

    Aromatase inhibitors (AIs) are now regarded as the optimum hormonal therapy for postmenopausal women with hormone receptor positive breast cancer. However, it is unclear which of the currently available AIs offers patients the most effective and the best-tolerated treatment strategy.

  • Lobular intraepithelial neoplasia: Outcomes and optimal management

    Lobular neoplasia is a term encompassing both atypical lobular hyperplasia and lobular carcinoma in situ. These pathological findings are of uncertain malignant potential and predispose to a higher lifetime risk of breast cancer.